कोशिश गोल्ड - मुक्त
Tata, Kalyani unlikely to tie up with HAL for Amca race; L&T picks BEL
Business Standard
|September 25, 2025
Tata Advanced Systems (TASL) and Kalyani group are leaning towards not tying up with state-owned Hindustan Aeronautics (HAL) as they prepare to qualify for developing the prototype of India’s first indigenous stealth fighter jet — the Advanced Medium Combat Aircraft (Amca), sources told Business Standard.
Full-scale model of the Advanced Medium Combat Aircraft, which was showcased at the 15th edition of Aero India in Bengaluru from February 10 to 14, 2025
(PIB)
Tata Advanced Systems (TASL) and Kalyani group are leaning towards not tying up with state-owned Hindustan Aeronautics (HAL) as they prepare to qualify for developing the prototype of India’s first indigenous stealth fighter jet — the Advanced Medium Combat Aircraft (Amca), sources told Business Standard.
With Larsen & Toubro (L&T) on Wednesday announcing its tieup with state-run Bharat Electronics (BEL), sources added that the only other very large private-sector players who remain potential candidates for a tieup with HAL are Adani group and Mahindra group. The government intends the Amca programme to serve as a pathway for setting up a parallel fighter jet production line.
Highlighting that a substantial number of private companies have approached HAL, sources said that the twoor three-party consortium (the maximum permitted) that HAL is expected to lead in pursuing the Amca programme could take one of two forms. Either the defence public sector undertaking (DPSU) will team up with one of the four or five largest private firms still in play alongside a smaller company, or it may choose to tie up entirely with smaller players — with the likes of Dynamatic Technologies and VEM Technologies being likely candidates in that category. In response to an emailed query, HAL declined to comment on the matter.
यह कहानी Business Standard के September 25, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Business Standard से और कहानियाँ
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
